Atrophy patterns in IVS10+16, IVS10+3, N279K, S305N, P301L, and V337M MAPT mutations
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: To use a case-control study to assess and compare patterns of gray matter loss across groups of subjects with different mutations in the microtubule-associated protein tau (MAPT) gene.
Methods: We identified all subjects from Mayo Clinic, Rochester, Minnesota, that screened positive for mutations in MAPT and had a head MRI (n = 22). Voxel-based morphometry was used to assess patterns of gray matter atrophy in groups of subjects with the IVS10+16, IVS10+3, N279K, S305N, P301L, and V337M mutations compared with age- and sex-matched controls.
Results: All MAPT groups showed gray matter loss in the anterior temporal lobes, with varying degrees of involvement of the frontal and parietal lobes. Within the temporal lobe, the subjects with IVS10+16, IVS10+3, N279K, and S305N mutations (mutations that influence the alternative splicing of tau pre–messenger RNA) all showed gray matter loss focused on the medial temporal lobes. In contrast to these groups, the subjects with P301L or V337M mutations (mutations that affect the structure of the tau protein) both showed gray matter loss focused on the lateral temporal lobes, with a relative sparing of the medial temporal lobe.
Conclusion: There seem to be differences in patterns of temporal lobe atrophy across the MAPT mutations, which may aid in the differentiation of the different mutation carriers. Furthermore, there seems to be a possible association between mutation function and pattern of temporal lobe atrophy.
Glossary
- ADPR=
- Alzheimer’s Disease Patient Registry;
- ADRC=
- Alzheimer’s Disease Research Center;
- AVLT=
- Auditory Verbal Learning Test;
- BNT=
- Boston Naming Test;
- bvFTD=
- behavioral variant frontotemporal dementia;
- bvFTD + P=
- behavioral variant frontotemporal dementia with parkinsonism;
- CDR-SB=
- Clinical Dementia Rating Scale sum of boxes;
- DD=
- disease duration;
- FDR=
- false discovery rate;
- FTLD=
- frontotemporal lobar degeneration;
- MAPT=
- microtubule-associated protein tau;
- MNI=
- Montreal Neurological Institute;
- mRNA=
- messenger RNA;
- NA=
- not applicable;
- PPA=
- primary progressive aphasia;
- STMS=
- Short Test of Mental Status;
- VBM=
- voxel-based morphometry.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Victoria Leavitt and Dr. Laura Hancock
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Articles
Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRNJ. L. Whitwell, C. R. Jack, Jr, B. F. Boeve et al.Neurology, March 02, 2009 -
Articles
Altered functional connectivity in asymptomatic MAPT subjectsA comparison to bvFTDJ.L. Whitwell, K.A. Josephs, R. Avula et al.Neurology, August 17, 2011 -
Articles
Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration?J.L. Whitwell, C.R. Jack, Jr., J.E. Parisi et al.Neurology, December 13, 2010 -
Articles
MRI correlates of neurofibrillary tangle pathology at autopsyA voxel-based morphometry studyJ. L. Whitwell, K. A. Josephs, M. E. Murray et al.Neurology, September 02, 2008


